article thumbnail

SAC Health Theft Incident and Multiple Ransomware Attacks Reported

HIPAA Journal

The break-in was discovered on March 4, 2022, with the subsequent investigation confirming on April 22, 2022, that six boxes of paper documents had been stolen from the facility, which included files relating to patients served by SAC Health in 1997 and between 2006 and 2020. Notification letters were sent to those individuals on May 3, 2022.

article thumbnail

An Overview of the New York OMIG Exclusion List

Provider Trust

In 2006, New York’s Office of the Medicaid Inspector General (OMIG) was established as an independent office within New York State’s Department of Health to combat fraud and abuse in New York State’s Medicaid program. As far as the numbers go, you might wonder how complete the OMIG List of Restricted and Excluded Providers is.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

20 Years for Ohio Cardiologist Sentenced in $29 Million Overbilling Scheme

The Health Law Firm

Rendon, said of a Westlake, Ohio cardiologist sentenced to 20 years in prison on Friday, December 18, 2015, "This defendant used his medical license as a license to steal." From 2006 to 2012, Dr.

article thumbnail

How HHS-OIG, Regulators Enforce Vendor Compliance

Provider Trust

Moon , for submitting claims while excluded from March 2006 through July 2013. This action was in addition to the 2018 settlement and sought these additional actions alleging that the clinics named in the complaint suffered significant gaps in licensing and supervision of therapists during the relevant time period.

article thumbnail

Comment K, Presumptions, and Medical Device Design Defects Under Texas Law

Drug & Device Law

2006) (reversal concerned warning issues); Blackmon v. Texas, unlike most states, enforces a strong statutory presumption that prescription medical product warnings complying with FDA requirements imposed by “pre-market approval or licensing of the product” are adequate as a matter of law. Hoffman-La Roche, Inc. 15, 2007); McNeil v.

FDA 59